Overview

Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction

Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This was a randomized, double-blinded, placebo-controlled, multiple-dose study in subjects with stable heart failure (HF) with reduced ejection fraction (HFrEF).
Phase:
Phase 2
Details
Lead Sponsor:
Stealth BioTherapeutics Inc.